PMPRB Hearing Panel issues order in Procysbi case

Imported from official source

Announcement

In an order dated October 13, 2022, the Hearing Panel directed Horizon to pay $22,028,977.26 to the Receiver General of Canada within 30 days of the date of the Order. It is the largest amount ever ordered by the Board in an excessive price hearing.

Ottawa, ON – Patented Medicine Prices Review Board

A Patented Medicine Prices Review Board (PMPRB) Hearing Panel has issued an order relating to the medicine Procysbi, manufactured and marketed in Canada by Horizon Therapeutics Canada.

On September 1, 2022, the Hearing Panel issued a decision that found that the price of Procysbi was excessive under section 83 and 85 of the Patent Act. In an order dated October 13, 2022, the Hearing Panel directed Horizon to pay $22,028,977.26 to the Receiver General of Canada within 30 days of the date of the Order. It is the largest amount ever ordered by the Board in an excessive price hearing. The Board has also ordered that the ceiling price of Procysbi be reduced to a non-excessive level. 

The PMPRB is an independent quasi-judicial body with a regulatory mandate to protect the interests of Canadian consumers by ensuring the prices of patented medicines sold in Canada are not excessive.

Patentees must file prices and sales information with the PMPRB at introduction, and twice a year afterward, for each strength of each dosage form of each patented medicine sold in Canada.

This is an extract. The publication continues at the source.

Source: Patented Medicine Prices Review Board. Licence

Read the original at the source: https://www.canada.ca/en/patented-medicine-prices-review/news/2022/11/pmprb-hearing-panel-issues-order-in-procysbi-case.html

Officially imported this from Patented Medicine Prices Review Board’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.

Provenance

Organization
Patented Medicine Prices Review Board — imported from official source
Official source
https://api.io.canada.ca/io-server/gc/news/en/v2?dept=patentedmedicinepricesreviewboard&sort=publishedDate&orderBy=desc&publishedDate%3E=2021-07-23&pick=50&format=atom&atomtitle=Patented%20Medicine%20Prices%20Review%20Board ATOM
Imported
October 03, 2026 20:43
Versions
1 recorded
Identity
https://www.canada.ca/en/patented-medicine-prices-review/news/2022/11/pmprb-hearing-pan...

Officially records where a publication came from, not whether it is true. Imported records are reproduced from an organization's own official source.